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As studies uncover the breadth of microbes associated with human life,
opportunities will emerge to manipulate and augment their functions in
ways that improve health and longevity. From involvement in the com-
plexities of reproduction and fetal/infant development, to delaying the
onset of disease, and indeed countering many maladies, microbes offer
hope for human well-being. Evidence is emerging to suggest that
microbes may play a beneficial role in body sites traditionally viewed as
being sterile. Although further evidence is required, we propose that
much of medical dogma is about to change significantly through recog-
nition and understanding of these hitherto unrecognized microbe–host
interactions. A meeting of the International Scientific Association for
Probiotics and Prebiotics held in Aberdeen, Scotland (June 2014), pre-
sented new views and challenged established concepts on the role of
microbes in reproduction and health of the mother and infant. This arti-
cle summarizes some of the main aspects of these discussions.
Introduction
Unless science finds a way to create a human being
entirely outside the womb, females will remain cen-
tral to the survival of humankind. This statement
might be delinquent to some, but more human
research is performed on males than females,1 and
most microbiome work focuses on chronic gut
disease rather than the female reproductive tract. In
some instances, ethical committees discourage
research on pregnant women for fear of damaging
the fetus, but more research is needed on issues par-
ticularly related to women. Having stated that, rela-
tively few studies have examined the role of the
microbiome in male fertility. In this review, we will
focus on the female.
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The process of reproduction is simple yet strewn
with complex processes, any one of which can be
problematic and even catastrophic to the fetus or
mother. Conception starts when sperm comes into
contact with the egg. Until recently, the site of con-
ception and fetal growth (fallopian tubes and uterus)
and the whole fetal environment was believed to be
sterile and that the baby was first exposed to micro-
organisms only during birth. Thus, microbes were
only pertinent to infections which impacted on fer-
tility or successful gestation. In June, 2014, a meet-
ing of the International Scientific Association for
Probiotics and Prebiotics was held in Aberdeen, Scot-
land, to discuss recent research on the role of
microbes in reproduction and health of the mother
and infant. This article presents a perspective on
these discussions.
Microbes and conception
The failure of the sperm–egg conception process is
not infrequent, and the study of infertility has pro-
vided useful insights into the details of the fertiliza-
tion process. Of infertility cases, one-third remain
unexplained, while the others are attributed to
infection or to anatomical and physiological prob-
lems. Some studies investigating unexplained infer-
tility have shown the presence of lactobacilli in
human follicular fluid.2 These bacteria, known for
their beneficial effects on health and their usage in
food, have been recently associated with embryo
maturation and transfer.2 This fascinating study also
reported a correlation between culturable microbes
and the cause of infertility and in vitro fertilization
(IVF) outcomes. The authors focused on the prob-
lematic pathogens rather than why fertility was asso-
ciated with lactobacilli. By recommending
antimicrobial therapy to increase the success rate of
IVF, the authors may have missed an opportunity to
discuss the adverse effects of such an approach.
Many of the bacterial types likely present in the
cervix and vagina are not easily cultured and thus
the study did not provide a clear picture of the pop-
ulation structure in this niche and which bacterial
species might need to be eradicated. The options for
therapy are either broad-spectrum agents that will
also disrupt the indigenous microbes, or narrow
spectrum agents that would not affect the entire
range of organisms, namely non-pathogenic Gram
positive, Gram negative, aerobes and anaerobes. This
could represent a failure of antibiotics to penetrate
biofilms or an inability to reach suitable minimal
inhibitory concentrations. As a consequence, the
efficacy of treatments for vaginal infections is often
poor.3,4 The normal microbiota does not recover
promptly following antimicrobial use,5,6 and thus if
lactobacilli are important for IVF, antimicrobial treat-
ment alone would not guarantee success. Moreover,
long-term adverse effects of antimicrobial therapy
are increasingly recognized, and while the mecha-
nisms are not fully understood, a general reduction
in use of these agents is warranted.7
The presence of lactobacilli reported in the ovaries
is itself interesting, particularly as an earlier study
failed to find any culturable bacteria in ovarian
tissue,8 and because the endometrium is protected
by physical barriers, antimicrobial peptides, comple-
ment, Toll-like receptors (TLRs), and other pattern
recognition receptors.9 It seems reasonable to argue
that the lactobacilli could have ascended from the
vagina and cervix along the fallopian tubes,
although systemic access via the gut epithelial mem-
brane and blood supply has been shown for lipo-
polysaccharides from Gram-negative bacteria.10 The
ovary is well protected, with proteins such as long
pentraxin 3 (PTX3), produced by innate immunity
cells in response to pro-inflammatory signals and
Toll-like receptor engagement. The protein recog-
nizes microbes, activates complement, facilitating
phagocyte recognition, but it also is essential in
female fertility by acting as a nodal point for the
assembly of the cumulus oophorus hyaluronan-rich
extracellular matrix.11 While neither this or any
other ‘protective’ proteins were investigated in the
human follicular fluid containing lactobacilli, the fact
that the bacteria were reportedly viable and the
female remained fertile suggests the organisms are in
a quiescent state, are tolerated by the host, or are
somewhat metabolically active and perform some
important as yet not understood function. Although
the fluid contains lysozyme, an enzyme that can be
bactericidal to Gram-positive bacteria,12 it did not
kill the lactobacilli, possibly because of peptidoglycan
modifications13 or organism dormancy. Furthermore,
the ovary has epithelial cells, and the follicular fluid
itself contains almost 500 proteins,14 various hor-
mones including estrogen, fatty acids, and likely has
sufficient nutrient content for bacteria to grow. It
seems unlikely that lactobacilli or other organisms
are rapidly multiplying or are at high numbers, but
are probably present in low numbers similar to the
microbiota of the breast.15
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While a quiescent state of bacteria adjacent to or
within epithelial cells is a known phenomenon,16 it
does not mean the lactobacilli are inactive. Indeed,
they can maintain esterase activity, intact cytoplas-
mic membrane, and a pH gradient when dormant,17
as well as potentially other metabolic processes
when in the host. Polycystic ovary syndrome (PCOS)
is a heterogeneous endocrine disorder which
increases the risk of developing type 2 diabetes mell-
itus and cardiovascular disease. A study of 217
women with PCOS and 48 healthy women as con-
trols demonstrated elevated levels of lactate, long-
chain fatty acids, triglyceride and very low-density
lipoprotein in plasma, while glucose, phosphatidyl-
choline, and high-density lipoprotein concentrations
were reduced in PCOS patients.18 The levels of
alanine, valine, serine, threonine, ornithine, phenyl-
alanine, tyrosine, and tryptophan were also
generally increased, while glycine and proline were
significantly reduced in PCOS samples. Dietary
changes, such as reduction in carbohydrate intake
affects insulin and may improve reproductive/
endocrine outcomes.19 Processes such as L-carnitine-
mediated beta-oxidation of fatty acids have a well-
established role in energy supply of oocytes and
embryos,20 and also protects bacterial cells from
damage due to free radicals.21 The number of bacte-
ria present in the ovary environment is presumably
low and it is unknown if they are enough to induce
measurable metabolomic changes. However, this is
an aspect that is worth pursuing given lactobacilli’s
metabolic fermentative properties.
While we can only speculate on what functions
lactobacilli might perform in the healthy ovary or
follicular fluid, other studies suggest a role for lacto-
bacilli in conception. One study found that lactoba-
cilli can protect human spermatozoa from radical
oxygen species in the presence of vaginal disorders,
thereby improving the fertilization potential of the
female host.22 Bacterial vaginosis (BV) is the most
prevalent vaginal disorder, and it is associated with
not only an increased rate of preterm labor,23 but
also reduced ability to conceive.24,25 In a study of
874 women with female factor infertility and 382
asymptomatic fertile women, the prevalence of BV
was significantly higher in the former (45.5% versus
15.4%), and the highest prevalence occurred in
patients with PCOS (60.1%) and unexplained infer-
tility (37.4%).26 But others disagree that BV affects
preterm labor.27 A longitudinal study found no dif-
ferences in the bacterial taxa, relative abundance
and frequency of community state types between
women who delivered at term and those who had
spontaneous preterm delivery. The inability of met-
ronidazole treatment of BV to alter preterm delivery
rates,28 would support the latter view, but the effec-
tiveness of clindamycin counters this.29 The fact that
BV therapy improved the pregnancy rate consider-
ably26 suggests that bacteria may play a role in con-
ception and successful pregnancy. Clearly, more
studies are needed to confirm this concept and
understand the mechanisms, especially the role of
lactobacilli in the follicular fluid. Intervention studies
that assess whether probiotic lactobacilli could
impact fertility and conception would also be
highly valid and probably a better approach than
antibiotics.
Fetal development and pregnancy duration
A study reporting the presence of bacteria in both
preterm and term fetal membranes is interesting for
two reasons: (i) it confirmed that there is a greater
spread and diversity of bacterial species in tissues of
women who had very preterm births; and (ii) it
showed that bacteria can be present without any
apparent complications.30 A recent report that the
fetus in healthy women is indeed exposed to bacte-
ria via the placenta,31 raises many questions. Some
have questioned whether appropriate controls
included blood and environmental samples, sug-
gested that a placental microbiome has not yet
been shown present in other mammalians, and that
there is a history of deriving ‘germ-free’ animals, so
the finding makes no sense in evolutionary terms.
In fairness, few have yet used modern technologies
at these sites in animals to test for the presence or
remnants of bacteria, either live, dead, or inert.
Still, there was more abundance, consistency, and
diversity of taxa,31 far exceeding that expected even
if maternal blood was contaminated from the oral
cavity,32 and numerous other studies have reported
culturable bacteria in endometrial curettage samples
obtained from fresh hysterectomies,33 in term pla-
centas,34 in fetal membranes,35 and in the basal
plate of placentas in women who delivered at term
with no evidence of infection.36 In terms of other
mammals, a microbiome has been shown in other
species.37
Further studies greatly strengthen the position
that bacteria reach the placenta and amnion. Oral
inoculation of a genetically labelled E. faecium strain
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to a group of pregnant mice led to its isolation and
PCR detection from the amniotic fluid of the inocu-
lated animals.38 The amniotic fluid was obtained by
cesarean section 2 days before the expected delivery
day to avoid contamination from maternal feces. In
contrast, it could not be detected in the samples
obtained from a non-inoculated control group. The
counts in the samples of amniotic fluid obtained
from the treated animals were ~2.6 log CFU/mL.
Bacteria were also isolated from amniotic fluid of
the non-treated animals although at a lower level
(~1.7 log CFU/mL). Later, it was found that bacterial
translocation from the gut to mesenteric lymph
nodes and mammary gland occurred during late
pregnancy and lactation in mice.39 During such a
period, human breast milk cells and maternal
peripheral blood mononuclear cells contain viable
bacteria. This mechanism could also explain the
presence of bacteria in amniotic fluid obtained from
healthy mice. Further studies are required to con-
firm these findings.
It is easy to state that the purpose of this potential
prenatal bacterial transfer is to prepare the fetus for
entry to a microbial world, but proving this presents
challenges. As an example, the above results may
appear contradictory with the fact that hysterectomy
has been the method of choice to rederive new
strains of germ-free animals.40 The pregnant uterus
is clamped off, removed, sterilized, and transferred
into a sterile isolator with a recipient germ-free
foster mother. The uterus is rinsed with distilled
water before removing the pups from the uterus and
transferring the surviving pups to the germ-free
foster mom. The rinsing step may wash out bacteria
as its concentration in amniotic fluid or placenta of
healthy hosts seems to be very low. Anyway, to our
knowledge, there are no studies on the bacterial load
of germ-free derived animals at their fetal stage.
It is obvious that germ-free mice reproduce, so
arguably microbes are not critical for conception and
pregnancy. However, they may play a key role for a
physiological reproduction as it is also true that
germ-free animals exhibit pronounced defects in
multiple aspects of their organs’ structure and func-
tion, often leading to digestive and reproductive dis-
orders. In addition, germ-free animals not only
contain abnormal numbers of several immune cell
types and immune cell products, but also have rele-
vant deficits in local and systemic lymphoid struc-
tures, including hypoplastic Peyer’s patches and a
decreased number of isolated lymphoid follicles.41
Therefore, any vertical bacterial transmission system
involving complex cross talk processes with immune
cells will be impaired in these animals.
Although germ-free animals are a wonderful
research tool and have greatly contributed to the
microbiota field, their use has some major draw-
backs. It has been stated that as gut microbiota is
crucial for a proper host development, altered
responses exhibited by germ-free animals might not
reflect what actually occurs in the natural setting.42
Therefore, it may be challenging to transfer results
obtained in a germ-free system to the same events
occurring in a conventional host.41 In fact, the sub-
sequent addition of bacteria to germ-free animals
after birth influences immune development,
improves sociability, and reduces anxiety,43–45
emphasizing the importance of the microbes.
Even though confirmative studies are welcomed
using sterilized and DNA-free surgical equipment
and handling processes, the probability that bacteria
are present in the placenta is tantalizing and pro-
motes the concept of a microbiome–human symbio-
sis throughout conception and gestation. The wide
array of non-pathogenic microbiota from the Firmi-
cutes, Tenericutes, Proteobacteria, Bacteroidetes, and
Fusobacteria phyla strongly suggests this microbiota
is not a minor contaminant, and the sample size of
320 subjects31 suggests this is not a chance finding.
In terms of fetal development, the presence of
DNA from Bifidobacterium spp. and Lactobacillus
rhamnosus in 34 human placentae (25 vaginal and
nine cesarean deliveries) suggested at least the possi-
bility of a degree of mother–fetus microbial signal-
ing.46 Other studies, albeit in mice, have shown that
when the gut microbiota of the mother changes, so
too can inflammation and energy loss, adiposity and
insulin insensitivity, all in turn affecting the fetus.47
As stated earlier, conditions like BV can influence
the duration of pregnancy. However, the presence of
viruses is potentially even more important. Although
few virome studies have been performed on the
female reproductive tract, a series of studies has
clearly shown that viral infection of the placenta or
amnion leads to a predisposition for bacterial
induced preterm labor.48–51 The viral infection might
alter the normal mechanism mediating the interac-
tion between the placenta/maternal tissues and the
normal microbiota present at the implantation site.
These changes most likely would induce damage to
the protective layers allowing additional bacterial
access. However, given the high prevalence of
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certain viruses in humans, for example a reasonably
stable population of around 1200 viral genotypes in
the human gut,52 one could speculate that viruses
may also give access to lactobacilli or bifidobacteria
without subsequent membrane damage and miscar-
riage. This is worthy of investigation.
It has been proposed that endogenous retrovirus-
es mediate regulatory evolution and that this is an
important mechanism underlying the evolution of
placental development.53 The suggestion is that ret-
roviruses integrated into the germ cell genome and
that viral activity is responsible for establishing the
ancestral trophoblast cell type through regulatory
recruitment of developmental genes. If true, such
host–viral association is intriguing. One implication
proposed by the author is that epigenetic aberra-
tions could cause global endogenous retroviral
repression and placental defects, such as pre-
eclampsia. At the very least, this viral–host associa-
tion would illustrate the central role of microbes in
reproduction.
Other pathogenic viral effects can occur during
pregnancy, with disturbances during the second tri-
mester from influenza infection being linked with
neurodevelopmental contribution to major affective
disorder, especially unipolar depressive disorder and
schizophrenia later in life.54 This further illustrates
the ability of microbes to influence life, but given
the prevalence of influenza infection, it also suggests
that protective effects are in place in many instances
to prevent this serious condition.
T cells and potentially also B cells have long been
studied in reproductive immunology, especially in
terms of tolerance mechanisms supporting fetal well-
being.55 This topic has been well reviewed else-
where,56 but can immune cells prepare the newborn
to ‘receive’ and tolerate certain microorganisms, and
if so could the maternal programming be modulated
to optimize the receptivity to certain microbial
types? Such questions remain unanswered, but
emerging evidence does suggest that microbes can
indeed affect fetal development. Could viral vaccines
administered to the mother, for example against
cytomegalovirus (CMV) and human papilloma virus,
affect the response of the newborn to certain organ-
isms? There is at least one study where
CMV-infected human fetal brains showed a higher
tropism for stem cells/radial glial cells.57 Clearly,
infections by a variety of organisms in utero can
affect fetal development and the short- and long-
term outcomes for the neonate,58 but could some
non-pathogenic organisms do the same in a manner
that benefits the fetus?
Vitamins are critical for the first 1000 days of life,
most notably folic acid for brain and nerve system
development.59 A number of these vitamins can be
produced by bacteria.60 Processes that involve
methionine and one carbon metabolism in response
to physiological, nutritional, and hormonal influ-
ences are critical for cellular and organ function,
and growth of the fetus.61 Indeed, amino acids
(lysine and methionine), functional amino acids
(histidine and ornithine), and a dipeptide (L-alanyl-L-
glutamine) essential for development can all be
produced by bacteria.62 Nutrient availability influ-
ences total bacterial numbers and species composi-
tion in the gut, but to date, no specific nutrients or
prebiotics have been examined to boost the micro-
bial production of compounds critical to the fetus.
Some developmental stages may be so important
that even nutritional interventions post-birth could
be too late. Severe malnourishment has been associ-
ated with significantly less diverse microbiota that is
only partially ameliorated following nutritional
interventions in infancy.63 It is already known that
diminished microbial diversity in infancy, and colo-
nization with specific pathogenic bacteria, is linked
with an elevated risk for allergy,64 and probiotic
intervention in the mother and newborn can
ameliorate this,65,66 although not all evidence is
supportive and many factors are contributory to
success or failure.67–69
The supplementation of folic acid during preg-
nancy came from a recognition of its importance in
fetal development. However, other compounds
might be worth considering, especially linoleic acid
given that the brain is composed of 60% fat. The
correlation between lower maternal intake of lino-
leic acid and autism spectrum disorder,70 and lower
levels of linoleic acid and Alzheimer’s disease later
in life,71 provide examples of how at least these fatty
acids are important. The ability of bifidobacteria and
lactobacilli to produce linoleic acids72,73 raises the
question of whether administration of these strains
as probiotics might improve brain development over
the first two trimesters and beyond. Environmental
chemicals, drugs, and maternal nutritional imbal-
ances can interfere with regulatory pathways
involved in heart development early in gestation. No
studies have examined probiotic intervention at this
stage of life, but the ability of lactobacilli to modu-
late cardiac modeling74 and counter environmental
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toxins75 suggest they could be worth investigating to
improve heart health.
Learning from mastitis
The importance of maternal milk in development of
the newborn is unquestioned. In addition to anti-
bodies, oligosaccharides and nutrients, the neonate
also receives microbes in the milk.76,77 It had long
been assumed that these comprised skin ‘contami-
nants’ from the mother, or potentially the baby
passed organisms it had acquired at birthing back
into the mammary ducts upon feeding. However,
recent studies have suggested that bacteria are
picked up by dendritic cells in the maternal gut and
transferred to the mammary ducts – perhaps as a
means to colonize the newborn through breast feed-
ing.78 Although this theory is still somewhat contro-
versial, a Lactobacillus salivarius CECT 5713, isolated
from maternal milk and the newborn baby’s feces,
has been sequenced and shown to have the poten-
tial to stimulate the maturation of immature den-
dritic cells and to inhibit the in vitro infectivity of
HIV-1.79 The latter could potentially be important in
reducing HIV infection to newborns, a characteristic
reported in vaginal lactobacilli.80,81 Another possibil-
ity, not yet investigated, is for bacteria to reach the
mammary gland via adsorption across the skin sur-
face directly into the fatty tissue or via the blood-
stream.82
The latter example cites work on Staphyococcus
aureus, better known for its ability to cause bacteremia,
wound infections, and mastitis. Over one-third of
women can suffer from mastitis during breastfeeding
women, resulting in cessation of feeding, and
administration of antibiotic and pain therapy.83 It is
actually defined as ‘inflammation of the breast’, but
invariably is associated with bacterial infection.
Interestingly, inflammatory changes of the breast
can range from benign self-limited processes such as
puerperal mastitis, to highly aggressive malignant
inflammatory carcinoma. The diagnosis of mastitis is
usually made by patients presenting with focal ten-
derness in one breast accompanied by fever and
malaise. The concept of using probiotic lactobacilli to
prevent and help treat mastitis is being consid-
ered,77,84 but data from managing the disease in
cows suggest that bacteriocins, antibacterial proteins
produced by one strain and that are active against
usually close relatives, are also worthy of consider-
ation.
Mastitis is a major problem faced by the dairy
industry. Over 137 different organisms have been
identified as being causative agents of bovine mastitis,
including bacteria, viruses, mycoplasma, yeasts, and
algae.85 This makes a generalized treatment difficult,
but as most cases, at least in the United Kingdom
and Ireland, are caused by Escherichia coli, S. aureus,
Streptococcus uberis, Strepococcus dysgalactiae, and Strep-
tococcus agalactiae,86 bacteriocin therapy could make a
significant impact. In a series of studies, a broad-
spectrum bacteriocin produced by the food-grade
Lactococcus lactis, Lacticin 3147 which is bactericidal
to streptococci and staphylococci in vitro, when
applied with a teat seal was found to significantly
prevented mastitis.87 Further studies showed
reduced incidence of mastitis after experimental
challenge with S. dysgalactiae and S. aureus.87,88
Mechanistically, infusion with live Lactococcus lactis
led to a rapid and considerable innate immune
response which may also form part of the efficacy.89
Given the failures of antibiotic therapy, this inter-
vention provides an illustration of the potential
power of the microbes. Such applications to humans
are certainly worthy of attempting, especially given
the option of local administration as well as via
ingestion and immunological modulation. In fact, a
preparation of nisin, another lactococcal bacteriocin,
has been successfully employed for the treatment of
human staphylococcal mastitis and nipple cracking
during lactation.90
The ability of naturally occurring microbes to treat
infections allows us to revisit the pre-antibiotic era.
It is known that some infections naturally resolve,
and competition from commensal microbes has been
suggested as one of the mechanisms.91 The dense
and complex bacterial population that exists in the
human colon arguably may offer a wealth of novel
antimicrobials,92 including bacteriocins as well as
candidate probiotic strains. Recently, Hatziioanou
et al.93 provided evidence of a novel bacteriocin-like
substance against Bacillus subtilis that is formed by
Roseburia faecis, an abundant species in the human
colon. The finding of substantial geographical varia-
tion in the composition and distribution of bacterial
species in human colonic94,95 and vaginal samples96
suggests there is merit in screening human samples
collected from various countries and ethnicities for
novel bacteriocin-producing bacteria and candidate
probiotics. For indigenous people, such as the Hadza
in Tanzania, a more close association with the
microbial world and their hunter–gatherer lifestyle
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certainly shapes their microbiome,97 and presumably
alters how they prevent, treat and recover from
infections, or indeed die from them. In Venezuelan
Hadza, infectious disease is a major killer,98 but of
those who live a relatively long life, it would be
interesting to examine how their microbiome has
evolved without vaccination or modern medicine.
Analysis of samples collected by Jeff Leach while
living with Hadza in Tanzania will soon provide
valuable insight into these questions.99
Conclusions
There seems little doubt that microorganisms are
central to human life and longevity (Fig. 1). While
death due to pathogenic microbes has been well
documented, recent studies indicate that commensal
organisms, and in some cases administered probiot-
ics, are helping to delay morbidity and mortality and
are playing a critical role in the continuation of
human life. The more we understand about our tiny
co-inhabitants, the better able we will be to manipu-
late and utilize them to our healthy advantage.
The study of internal maternal transmission of
microbes in mammals is in its infancy due to the
enduring influence of the sterile womb paradigm and
to the ethical and technical difficulties of collecting
samples from healthy pregnancies before birth. Thus,
we still know very little about the number and iden-
tity of microbes that traverse the placenta, whether
they persist in the infant or if their presence has
long-term health consequences. The ability of probi-
otic bacteria, administered to pregnant women, to
modulate the fetal intestinal immune gene expres-
sion and placental physiology suggests host–microbe
interactions take place at this site.100 While maternal
transmission of microbes in vertebrate species has
only been recognized in the last few years, nearly a
century’s worth of research is available for vertical
transmission of symbionts in invertebrates. Maternal
provisioning of microbes to developing offspring is
widespread in the metazoan world, with evidence of
internal microbial transmission in animal phyla as
diverse as Porifera, Cnidaria, Mollusca, Platyhelmin-
thes, Nematoda, Arthropoda and Chordata.101 The
presence of maternal transmission at the base of the
Animalia Kingdom and the surprising plasticity by
which microbes gain access to germ cells or embryos
in these systems signifies that maternal symbiont
transmission is an ancient and evolutionary advanta-
geous mechanism that is inherent in animals. There-
fore, we can no longer ignore the fact that exposure
to microbes in the womb is more common than pre-
viously thought and may even be a normal part of
human pregnancy as the first inoculation of benefi-
cial microbes to an unborn child.
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